| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2987203 | The Journal of Thoracic and Cardiovascular Surgery | 2006 | 11 Pages |
Abstract
Glucose-insulin-potassium therapy improves early postoperative cardiovascular performance, reduces inotrope requirement, and might reduce myocardial injury. These potential benefits are not at the expense of increased noncardiac morbidity.
Keywords
WBGNYHAITUcTnIGIKIQRSVRICPBLCOESVRelectrocardiogramECGNew York Heart Associationstandard deviationperioperative myocardial infarctioncardiopulmonary bypasscoronary artery bypass graftinganalysis of varianceANOVACABGcardiac indexsystemic vascular resistance indexPMIAtrial fibrillationcardiac troponin Iinterquartile rangeSystemic vascular resistanceintensive therapy unitglucose-insulin-potassium
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David W. (FRCS), Domenico (FRCS, FESC), Robert S. (FRCP, FRCS, FESC), Stephen J. (FRCS), Timothy R. (FRCS), Ian C. (FRCS), Bruce E. (FRCS), John N. (FRCP), Michael E. (FRCS), Peter PhD, Study Investigators Study Investigators,